NR4A2 and Parkinson disease: The potential endogenous functions of PGE1 and PGE2 (Fig. 4D,E) have recently been reported; both compounds bind NR4A2, inhibit inflammation in neuronal cells and are neuroprotective in the MPTP-induced Parkinson’s Disease mouse model (Rajan et al., 2020).